Provided by Tiger Trade Technology Pte. Ltd.

Exagen

4.58
-0.0600-1.29%
Post-market: 4.580.00000.00%17:05 EDT
Volume:404.58K
Turnover:1.91M
Market Cap:110.16M
PE:-5.20
High:5.01
Open:4.73
Low:4.53
Close:4.64
52wk High:12.23
52wk Low:2.59
Shares:24.05M
Float Shares:15.92M
Volume Ratio:2.08
T/O Rate:2.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8813
EPS(LYR):-0.9300
ROE:-193.58%
ROA:-19.13%
PB:7.63
PE(LYR):-4.92

Loading ...

Exagen Q1 EPS $(0.17) Beats $(0.23) Estimate, Sales $17.306M Beat $16.414M Estimate

Benzinga
·
May 11

Exagen Inc - Maintains FY2026 Revenue Guidance of $70 Mln to $73 Mln

THOMSON REUTERS
·
May 11

Exagen Inc. Q1 Operating Expenses USD 13.619 Million

THOMSON REUTERS
·
May 11

Exagen Inc. Q1 Revenue USD 17.306 Million VS. Ibes Estimate USD 16.4 Million

THOMSON REUTERS
·
May 11

Exagen Inc. Reports First Quarter 2026 Results

GlobeNewswire
·
May 11

Exagen Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 08

Exagen announces annual shareholder meeting

Reuters
·
Apr 28

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

GlobeNewswire
·
Apr 27

Exagen Announces Board Resignation and Committee Restructuring

TIPRANKS
·
Apr 24

Exagen director Ana Hooker resigns from board, committees effective immediately

Reuters
·
Apr 24

Envoy Medical names Charles McKhann to board, Compensation Committee

Reuters
·
Apr 22

Exagen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 21

Exagen price target lowered to $8 from $10 at Canaccord

TIPRANKS
·
Apr 20

Exagen Inc. files initial beneficial ownership statement for director Chas McKhann

Reuters
·
Mar 17

B. Riley Securities Keeps Their Buy Rating on Exagen (XGN)

TIPRANKS
·
Mar 12

Exagen price target lowered to $10 from $12 at Craig-Hallum

TIPRANKS
·
Mar 11

Exagen (XGN) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Mar 11

Exagen price target lowered to $10 from $15 at KeyBanc

TIPRANKS
·
Mar 11

Exagen price target lowered to $9 from $10 at BTIG

TIPRANKS
·
Mar 11

Exagen Is Maintained at Buy by BTIG

Dow Jones
·
Mar 11